Evidence map›Paper›PMID 41646209›Full record

ArticleESMO real world data and digital oncology2025

Systematic curation and analysis of ovarian cancer data across multiple electronic record systems held within the UK National Health Service: a tertiary referral centre experience.

A Samani, G Giannone, L Mercuri, R Jiang, Y Nadkarni, A Chadha, E Xing, S Ghaem-Maghami, J Krell, D Lyons and 6 more

Abstract read
In one paragraph

Article in ESMO real world data and digital oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

A SamaniDepartment of Oncology, Imperial College Healthcare NHS Trust, London, UK.
G GiannoneDepartment of Oncology, Imperial College Healthcare NHS Trust, London, UK.
L MercuriiCARE Secure Data Environment, NIHR Imperial Biomedical Research Centre, London, UK.
R JiangDepartment of Surgery and Cancer, Imperial College London, London, UK.
Y NadkarniDepartment of Oncology, Imperial College Healthcare NHS Trust, London, UK.
A ChadhaDepartment of Surgery and Cancer, Imperial College London, London, UK.
E XingDepartment of Oncology, Imperial College Healthcare NHS Trust, London, UK.
S Ghaem-MaghamiDepartment of Surgery and Cancer, Imperial College London, London, UK.
J KrellDepartment of Oncology, Imperial College Healthcare NHS Trust, London, UK.
D LyonsDepartment of Gynaecology, Imperial College Healthcare NHS Trust, London, UK.
C FotopoulouDepartment of Surgery and Cancer, Imperial College London, London, UK.
D PapadimitriouiCARE Secure Data Environment, NIHR Imperial Biomedical Research Centre, London, UK.
B GlampsoniCARE Secure Data Environment, NIHR Imperial Biomedical Research Centre, London, UK.
E MayerDepartment of Surgery and Cancer, Imperial College London, London, UK.
I McNeishDepartment of Oncology, Imperial College Healthcare NHS Trust, London, UK.
L TookmanDepartment of Oncology, Imperial College Healthcare NHS Trust, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Manual curation of real-world data (RWD) for patients with ovarian cancer is complex and costly. We set up a novel collaboration between informatics and clinical teams generating automated data curation at scale. This enabled integrated and timely access to RWD across all ovarian cancer patients treated within a tertiary gynaecological cancer centre of the UK National Health System, setting the basis for research and operational use. Materials and methods: The collaboration defined high-yield, accessible data which were pulled into tables representing various clinical domains followed by a systematic integration, cleaning and analysis within the iCARE Secure Data Environment. Results: We curated data for 1581 patients diagnosed between 1 January 2014 and 31 December 2022. We showed that referrals to the specialist tumour board consistently increased over time while baseline characteristics did not change significantly. The number of patients receiving a new line of therapy decreased in 2020, the first year of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak. Data robustness was supported using multivariate survival modelling demonstrating the expected impact of known prognostic factors. There was a paucity of available data for some variables (e.g. ethnicity) while others lacked a consistent storage mechanism within source systems (genomic data). Conclusions: Automated curation and analysis of RWD is possible at scale, in real time. Analysis yielded clinical findings consistent with the prevalent literature and showed evolution of treatment practice. While not all unstructured data could be explored, we demonstrate that automated curation of clinically important real-world variables is feasible and can yield robust data for both research and operational purposes.

Indexed as

automationovarian cancerreal-world data

Identifiers

PMID41646209
PMCPMC12836614

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.